Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles (Q107072776)

1

0 references

Nazar Beirag

2

0 references

Valarmathy Murugaiah

3

0 references

Yu-Chi Chou

4

0 references

Wen-Shuo Kuo

5

0 references

Hui-Fang Kao

6

0 references

Taruna Madan

7

0 references

Uday Kishore

8

0 references

Jiu-Yao Wang

Creative Commons Attribution 4.0 International

9

0 references

language of work or name

English

0 references

publication date

2021

0 references

published in

Frontiers in Immunology

0 references

volume

12

0 references

page(s)

641360

0 references

copyright license

start time

14 May 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Surfactant proteins SP-A and SP-D: structure, function and receptors.

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Pulmonary surfactant protein D in first-line innate defence against influenza A virus infections.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein D

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Infection of human alveolar macrophages by human coronavirus strain 229E.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Coronaviruses and SARS-CoV-2: A Brief Overview

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Identification of Coronavirus Isolated from a Patient in Korea with COVID-19

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

IL-6: relevance for immunopathology of SARS-CoV-2

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Pathogenesis of COVID-19-induced ARDS: implications for an aging population

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: mini-review of the literature

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines via Fas-Mediated Pathway.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

A human monoclonal antibody blocking SARS-CoV-2 infection

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Structural basis of receptor recognition by SARS-CoV-2

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Receptor recognition mechanisms of coronaviruses: a decade of structural studies

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Human Coronavirus: Host-Pathogen Interaction

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

The international response to the outbreak of SARS in 2003.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Recognition of Mannosylated Ligands and Influenza A Virus by Human Surfactant Protein D: Contributions of an Extended Site and Residue 343 † , ‡

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Soluble host defense lectins in innate immunity to influenza virus

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

The Immunobiology of SARS*.

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

A major outbreak of severe acute respiratory syndrome in Hong Kong

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360

Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS

2 June 2021

1 reference

https://api.crossref.org/works/10.3389/FIMMU.2021.641360